Human respiratory syncytial virus diversity and epidemiology among patients hospitalized with severe respiratory illness in South Africa, 2012–2015
dc.contributor.author | Ziyaad Valley-Omar | |
dc.contributor.author | Stefano Tempia | |
dc.contributor.author | Orienka Hellferscee | |
dc.contributor.author | Sibongile Walaza | |
dc.contributor.author | Ebrahim Variava6 | |
dc.contributor.author | Halima Dawood | |
dc.contributor.author | Kathleen Kahn | |
dc.contributor.author | Meredith McMorrow | |
dc.contributor.author | Marthi Pretorius | |
dc.contributor.author | Senzo Mtshali | |
dc.contributor.author | Ernest Mamorobela | |
dc.contributor.author | Nicole Wolter | |
dc.contributor.author | Marietjie Venter | |
dc.contributor.author | Anne von Gottberg | |
dc.contributor.author | Cheryl Cohen | |
dc.contributor.author | Florette K. Treurnicht | |
dc.date.accessioned | 2024-05-16T10:29:15Z | |
dc.date.available | 2024-05-16T10:29:15Z | |
dc.date.issued | 2015 | |
dc.description.abstract | Background: We aimed to describe the prevalence of human respiratory syncytial virus (HRSV) and evaluate associations between HRSV subgroups and/or genotypes and epidemiologic characteristics and clinical outcomes in patients hospitalized with severe respiratory illness (SRI). Methods: Between January 2012 and December 2015, we enrolled patients of all ages admitted to two South African hospitals with SRI in prospective hospital-based syndromic surveillance. We collected respiratory specimens and clinical and epidemiological data. Unconditional random effect multivariable logistic regression was used to assess factors associated with HRSV infection. Results: HRSV was detected in 11.2% (772/6908) of enrolled patients of which 47.0% (363/772) were under the age of 6 months. There were no differences in clinical outcomes of HRSV subgroup A-infected patients compared with HRSV subgroup B-infected patients but among patients aged <5 years, children with HRSV subgroup A were more likely be coinfected with Streptococcus pneumoniae (23/208 11.0% vs. 2/90, 2.0%; adjusted odds ratio 5.7). No significant associations of HRSV A genotypes NA1 and ON1 with specific clinical outcomes were observed. Conclusions: While HRSV subgroup and genotype dominance shifted between seasons, we showed similar genotype diversity as noted worldwide. We found no association between clinical outcomes and HRSV subgroups or genotypes. | |
dc.description.librarian | PM2023 | |
dc.faculty | Faculty of Health Sciences | |
dc.identifier.uri | https://hdl.handle.net/10539/38479 | |
dc.language.iso | en | |
dc.school | Public Health | |
dc.subject | human respiratory syncytial virus, severe respiratory illness, South Africa | |
dc.title | Human respiratory syncytial virus diversity and epidemiology among patients hospitalized with severe respiratory illness in South Africa, 2012–2015 | |
dc.type | Article |